Editing
Sexually Transmitted Infections
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Human papillomavirus (HPV) === ==== Pathogen ==== * '''Double-stranded DNA virus''' (similar to herpes) ** '''Non-oncogenic subtypes: 6 and 11; account for β90% of anogenital warts, also known as condyloma acuminata''' ** '''Oncogenic subtypes: 16 and 18; account for cervical cancer and other types of anogenital cancer including penile, vulvar, vaginal, anal cancers; subtype 16 more important for penile cancer''' ==== Epidemiology ==== * > 50% of sexually active persons will become infected at least once in their lifetime ==== Natual history ==== * β70% of HPV infections resolve spontaneously in 1 year and 90% in 2 years, and HPV persistence develops in the remaining persons ==== Pathogenesis ==== * Transmission can occur from asymptomatic and subclinical patients. ** Among asymptomatic females in the general population, the prevalence of HPV infection ranges from 2-44%, and among men from 2-35% * Risk factors: presence of foreskin, increasing numbers of sexual partners, lack of condom use, and smoking. ==== Diagnosis and Evaluation ==== * '''See Figure''' * '''HPV warts can also occur in the urethra and can cause hematuria, dysuria, or difficulty voiding''' ==== Management ==== * '''The goal of treatment is removal of the warts; treatment will not eradicate the infection.''' ** '''Treatment is guided by wart size, number, and location, and patient preference.''' * '''Options classified as patient-applied vs. provider-administered modalities''' ** '''Patient-applied (3):[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620174/table/t1-cuaj-6-s2/?report=objectonly Β§]''' **# '''Imiquimod cream, 3.75 or 5%, should be applied for 8 hrs daily for 2 weeks''' **##'''Maximum of 8 weeks for 3.75% vs. 16 weeks every other day for 5% imiquimod''' **# '''Podofilox cream, 0.5%, applied twice daily for 3 consecutive days each week, can repeat up to 4 weeks with at least 4 days in between''' **# '''Sinecatechins ointment, 15%, applied 3 times daily for up to 16 weeks''' ** '''Provider-administered (4):''' **# '''Podophyllin''' (less refined form of podofilox) **# '''Trichloroacetic acid''' **# '''Cryotherapy''' **# '''Surgical therapy including direct excision with scissors, tangential shave excision, curettage, or laser therapy using a CO2 laser''' * '''HPV vaccine''' ** '''Designed to prevent infection and are not effective in clearing an infection once established''' ** '''Recommended for females AND males age < 26''', preferably to start before onset of sexual activity. ** '''Gardasil''' *** '''Quadrivalent HPV vaccine that provides protection against HPV types 6, 11, 16, and 18.''' ** '''Cervarix''' *** '''Bivalent HPV vaccine that provides protection against HPV types 16 and 18'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information